Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Issue 3 (September 2015)

• Record Type: Journal Article
• Authors: Braam, H.J.; Schellens, J.H.; Boot, H.; van Sandick, J.W.; Knibbe, C.A.; Boerma, D.; van Ramshorst, B.
• Is Part Of: Critical reviews in oncology/hematology. Volume 95:Issue 3(2015)
• Page Start: 282
• Page End: 296
• Publication Date: 2015-09
• Subjects: Oncology -- Periodicals; Hematology -- Periodicals; 616.994
• DOI: 10.1016/j.critrevonc.2015.04.004
• Languages: English
• ISSNs: 1040-8428

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">HIPEC has potential benefit in gastric cancer.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">A literature search is present to determine which drugs are most suitable.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">At present the optimal chemotherapeutic regime is unknown.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">The wide variety in parameters warrants studies to determine the optimal schedule.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">A combination of drugs probably results in a more effective treatment.</p> </list-item> </list> </p> </sec> </abstract>